Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is 1.08x as of 2026-10-06T14:27:00.433Z.
Calculation as of: 2026-10-06T14:27:00.433Z.
Quote observation: 2026-10-06T14:24:57.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6dd2a4984e4340952b62e9ecd156f35eed99e3c78779d37ae6f95d3f5c845125
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
1.08x
SECTOR MEDIAN · HEALTHCARE
1.50x
median of 533 covered companies
CURRENT VS SECTOR MEDIAN
-28.00%
vs the sector median at left
Market Cap
$1.15B
EV/Assets Ratio
0.60x
TTM Avg
0.79x
3Y Avg
1.35x
5Y Avg
2.11x
Market Cap
$1.13B
EV/Assets Ratio
2.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.15B
EV/Assets Ratio
1.12x
TTM Avg
1.48x
3Y Avg
1.40x
5Y Avg
0.68x
Market Cap
$1.18B
EV/Assets Ratio
1.16x
TTM Avg
3.18x
3Y Avg
1.74x
5Y Avg
1.41x
Market Cap
$1.13B
EV/Assets Ratio
3.22x
TTM Avg
4.44x
3Y Avg
3.71x
5Y Avg
3.50x
Market Cap
$1.19B
EV/Assets Ratio
2.01x
TTM Avg
2.64x
3Y Avg
3.36x
5Y Avg
3.81x
Market Cap
$1.11B
EV/Assets Ratio
0.90x
TTM Avg
0.93x
3Y Avg
1.40x
5Y Avg
1.78x
Market Cap
$1.10B
EV/Assets Ratio
1.97x
TTM Avg
2.06x
3Y Avg
1.63x
5Y Avg
1.63x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kardigan, Inc. (KARD) | $1.15B | 1.08x | N/A | N/A | N/A |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 0.60x | 0.79x | 1.35x | 2.11x |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 2.08x | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.15B | 1.12x | 1.48x | 1.40x | 0.68x |
| Nektar Therapeutics (NKTR)vs › | $1.18B | 1.16x | 3.18x | 1.74x | 1.41x |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 3.22x | 4.44x | 3.71x | 3.50x |
| MannKind Corporation (MNKD)vs › | $1.19B | 2.01x | 2.64x | 3.36x | 3.81x |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | 0.90x | 0.93x | 1.40x | 1.78x |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.10B | 1.97x | 2.06x | 1.63x | 1.63x |
| Cronos Group Inc. (CRON)vs › | $1.22B | 0.64x | 0.27x | 0.19x | 0.18x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
